Back to results
CompletedEARLY_Phase 1

A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A)

NCT02269540

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Research Imaging Centre, Centre for Addiction and Mental Health

Toronto, Ontario, Canada

View on ClinicalTrials.gov
A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A) — TrialFind